These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 38659239)

  • 1. Structural Pharmacology of TRPV4 Antagonists.
    Fan J; Guo C; Liao D; Ke H; Lei J; Xie W; Tang Y; Tominaga M; Huang Z; Lei X
    Adv Sci (Weinh); 2024 Jul; 11(25):e2401583. PubMed ID: 38659239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis of TRPV1 inhibition by SAF312 and cholesterol.
    Fan J; Ke H; Lei J; Wang J; Tominaga M; Lei X
    Nat Commun; 2024 Aug; 15(1):6689. PubMed ID: 39107321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cryo-EM and X-ray structures of TRPV4 reveal insight into ion permeation and gating mechanisms.
    Deng Z; Paknejad N; Maksaev G; Sala-Rabanal M; Nichols CG; Hite RK; Yuan P
    Nat Struct Mol Biol; 2018 Mar; 25(3):252-260. PubMed ID: 29483651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural insight into tetrameric hTRPV1 from homology modeling, molecular docking, molecular dynamics simulation, virtual screening, and bioassay validations.
    Feng Z; Pearce LV; Xu X; Yang X; Yang P; Blumberg PM; Xie XQ
    J Chem Inf Model; 2015 Mar; 55(3):572-88. PubMed ID: 25642729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural determinants of TRPV4 inhibition and identification of new antagonists with antiviral activity.
    Doñate-Macian P; Duarte Y; Rubio-Moscardo F; Pérez-Vilaró G; Canan J; Díez J; González-Nilo F; Valverde MA
    Br J Pharmacol; 2022 Jul; 179(14):3576-3591. PubMed ID: 32959389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRPV4-Rho GTPase complex structures reveal mechanisms of gating and disease.
    Kwon DH; Zhang F; McCray BA; Feng S; Kumar M; Sullivan JM; Im W; Sumner CJ; Lee SY
    Nat Commun; 2023 Jun; 14(1):3732. PubMed ID: 37353484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRPV4 antagonists: a patent review (2015-2020).
    Lawhorn BG; Brnardic EJ; Behm DJ
    Expert Opin Ther Pat; 2021 Sep; 31(9):773-784. PubMed ID: 33724130
    [No Abstract]   [Full Text] [Related]  

  • 8. TRPV4 agonists and antagonists.
    Vincent F; Duncton MA
    Curr Top Med Chem; 2011; 11(17):2216-26. PubMed ID: 21671873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural insight into the assembly of TRPV channels.
    Huynh KW; Cohen MR; Chakrapani S; Holdaway HA; Stewart PL; Moiseenkova-Bell VY
    Structure; 2014 Feb; 22(2):260-8. PubMed ID: 24373766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural and biochemical consequences of disease-causing mutations in the ankyrin repeat domain of the human TRPV4 channel.
    Inada H; Procko E; Sotomayor M; Gaudet R
    Biochemistry; 2012 Aug; 51(31):6195-206. PubMed ID: 22702953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of the TRPV4 ion channel as a therapeutic target for disease.
    Grace MS; Bonvini SJ; Belvisi MG; McIntyre P
    Pharmacol Ther; 2017 Sep; 177():9-22. PubMed ID: 28202366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRPV4-pathy, a novel channelopathy affecting diverse systems.
    Dai J; Cho TJ; Unger S; Lausch E; Nishimura G; Kim OH; Superti-Furga A; Ikegawa S
    J Hum Genet; 2010 Jul; 55(7):400-2. PubMed ID: 20505684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The structural changes of the mutated ankyrin repeat domain of the human TRPV4 channel alter its ATP binding ability.
    Li D; Kao TH; Chang SW
    J Mech Behav Biomed Mater; 2020 Jan; 101():103407. PubMed ID: 31493693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis of TRPV5 channel inhibition by econazole revealed by cryo-EM.
    Hughes TET; Lodowski DT; Huynh KW; Yazici A; Del Rosario J; Kapoor A; Basak S; Samanta A; Han X; Chakrapani S; Zhou ZH; Filizola M; Rohacs T; Han S; Moiseenkova-Bell VY
    Nat Struct Mol Biol; 2018 Jan; 25(1):53-60. PubMed ID: 29323279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural determinants of 5',6'-epoxyeicosatrienoic acid binding to and activation of TRPV4 channel.
    Berna-Erro A; Izquierdo-Serra M; Sepúlveda RV; Rubio-Moscardo F; Doñate-Macián P; Serra SA; Carrillo-Garcia J; Perálvarez-Marín A; González-Nilo F; Fernández-Fernández JM; Valverde MA
    Sci Rep; 2017 Sep; 7(1):10522. PubMed ID: 28874838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein informatics combined with multiple data sources enriches the clinical characterization of novel TRPV4 variant causing an intermediate skeletal dysplasia.
    Hines SL; Richter JE; Mohammad AN; Mahim J; Atwal PS; Caulfield TR
    Mol Genet Genomic Med; 2019 Mar; 7(3):e566. PubMed ID: 30693671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRPV4 channel activity is modulated by direct interaction of the ankyrin domain to PI(4,5)P₂.
    Takahashi N; Hamada-Nakahara S; Itoh Y; Takemura K; Shimada A; Ueda Y; Kitamata M; Matsuoka R; Hanawa-Suetsugu K; Senju Y; Mori MX; Kiyonaka S; Kohda D; Kitao A; Mori Y; Suetsugu S
    Nat Commun; 2014 Sep; 5():4994. PubMed ID: 25256292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances on the structure and the function relationships of the TRPV4 ion channel.
    Sánchez-Hernández R; Benítez-Angeles M; Hernández-Vega AM; Rosenbaum T
    Channels (Austin); 2024 Dec; 18(1):2313323. PubMed ID: 38354101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward elucidating the heat activation mechanism of the TRPV1 channel gating by molecular dynamics simulation.
    Wen H; Qin F; Zheng W
    Proteins; 2016 Dec; 84(12):1938-1949. PubMed ID: 27699868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L596-W733 bond between the start of the S4-S5 linker and the TRP box stabilizes the closed state of TRPV4 channel.
    Teng J; Loukin SH; Anishkin A; Kung C
    Proc Natl Acad Sci U S A; 2015 Mar; 112(11):3386-91. PubMed ID: 25737550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.